(IN BRIEF) Evonik is now offering customers cradle-to-gate Life Cycle Assessment (LCA) data for selected EUDRAGIT® functional polymers, using its TÜV-certified LCA methodology to support pharmaceutical companies with transparent environmental data for Scope 3 emissions reporting. The data is currently … Read the full press release
Posted in Business, Chemicals, Environment, Healthcare, Industrial, Pharma & Biotech, Science, Technology
Tagged 2030 sustainability targets, climate neutrality, coatings, cradle-to-gate assessment, Custom Solutions, Darmstadt, data-driven decisions, delayed release, Dr Jürgen Krauter, drug delivery, emissions reporting, energy use, environmental footprint, environmental transparency, ESG requirements, Essen, EUDRAGIT, EUDRAGIT L 100-55, EUDRAGIT L 30 D-55, EUDRAGIT® L 100-55 Shows 6 Percent Product Carbon Footprint Reduction, Evonik, Evonik Expands Sustainability Transparency for EUDRAGIT® Functional Polymers, Evonik Health Care, Evonik Industries AG, Evonik Offers Cradle-to-Gate LCA Data for Pharmaceutical Excipients, Functional Polymers, Germany, healthcare sustainability, hot melt extrusion, immediate release, Janusz Berger, LCA data, life cycle assessment, Muhammad Irfan, Next Generation Solutions, Oral Drug Delivery Solutions, PCF, pharmaceutical excipients, pharmaceutical processes, pharmaceutical products, pharmaceutical value chain, polymethacrylates, poorly soluble drug substances, process efficiency, product carbon footprint, renewable electricity, Scope 1 emissions, scope 2 emissions, Scope 3 emissions, solubility enhancement, spray drying, spray drying system, surface treatments, sustainability strategy, sustained release, Thilo Krapfl, TRANSPORT, TÜV-certified LCA methodology
(IN BRIEF) Evonik and Higuchi Inc. have launched a new joint laboratory in Yokohama, Japan, to advance oral drug delivery innovation and support pharmaceutical companies with localized technical expertise. The Open Pharma Lab will provide access to Evonik’s EUDRAGIT® polymers … Read the full press release
Posted in Business, Chemicals, Germany, Industrial, Investment, Management, Pharma & Biotech
Tagged Asia market, biotechnology, drug delivery, EUDRAGIT® Polymers, Evonik expands Asia innovation network with new Yokohama lab in partnership with Higuchi, Evonik Industries, excipients, formulation development, Guido Skudlarek, Healthcare, Higuchi Inc, Open Pharma Lab, pharmaceutical innovation, Wataru Ohama, Yokohama Japan
(IN BRIEF) SCHOTT Pharma has launched the industry’s first 5.5 ml prefillable staked-needle glass syringe, expanding its syriQ BioPure® platform to support biologic therapies designed for home administration. The syringe integrates seamlessly with Ypsomed’s YpsoMate® 5.5 ml autoinjector and Datwyler’s … Read the full press release
Posted in Business, Germany, Healthcare, Industrial, News, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, autoinjector, biologic therapies, biopharmaceuticals, chronic disease treatment, CPHI Frankfurt, Datwyler, drug delivery, glass syringe, Healthcare Innovation, homecare, large-volume injector, medical technology, patient care, pharmaceutical innovation, SCHOTT Pharma, SCHOTT Pharma and Ypsomed drive innovation in large-volume injectable drug delivery with new 5.5 ml syringe, SCHOTT Pharma unveils 5.5 ml BioPure glass syringe to advance home-based biologic treatments, Subcutaneous Injection, syriQ BioPure, tungsten-free syringe, Ulrike Bauer, YpsoMate, Ypsomed
(IN BRIEF) Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm’s expertise in customized nucleic acids with Evonik’s advanced lipid and lipid nanoparticle (LNP) drug product development solutions. This collaboration aims … Read the full press release
Posted in Business, Chemicals, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged active ingredients, capping library screening, clinical trials, drug delivery, drug development, drug product development, enzymatic biotransformation, Evonik, Evonik capabilities, Fill & Finish, gene delivery, gene therapies, GMP manufacturing, Health Care Business, Kris S. Choi, life sciences sector, lipid nanoparticle, lipids, liposomes, LNP, mRNA development, mRNA-LNPs, North America manufacturing, nucleic acid medicines, nucleic acid therapeutics, nucleic acid therapies, Nutrition & Care division, oligonucleotides, partnership, pharmaceutical companies, RNA market, RNA therapeutics, siRNAs, small molecules, SmartCap® technology, South Korea, ST Pharm, strategic partnership, Yann d'Hervé
(IN BRIEF) Professor Remco Tuinier and his team at Eindhoven University of Technology have developed a new method to slow the release of protein-based drugs, addressing the challenge of rapid dispersion in the body. By using polyethylene glycol (PEG) and … Read the full press release
(IN BRIEF) Specialty chemicals company Evonik has opened a lipid launch facility at its site in Hanau, Germany. The good manufacturing practice facility, which opened on 8 March 2023, will enable Evonik to provide customers with quantities of lipids as … Read the full press release
Posted in Chemicals, Germany, Healthcare, News, Pharma & Biotech, Science
Tagged drug delivery, Evonik, health, health care, lipid, Nutrition, Paul Spencer, PhytoChol®, Thomas Riermeier
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?